Pyrrolitinib Maleate Tablets
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Pyrrolitinib Maleate Tablets, covering 2024-06-24 to 2024-06-24. Get the full timeline:
Most recent: Clinical Trial Update: A Real-World Study of Pyrrolitinib Maleate Tablets for HER-2-Positive Early or Locally Advanced Breast Cancer After Adjuvant Trastuzumab Therapy [Phase 1, Phase 2]